490
Views
6
CrossRef citations to date
0
Altmetric
REVIEW

The Safety and Efficacy of Mesenchymal Stem Cells in the Treatment of Type 2 Diabetes- A Literature Review

, &
Pages 769-777 | Received 04 Oct 2022, Accepted 24 Jan 2023, Published online: 14 Mar 2023

Reprints and Permissions

Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.

To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.

For more information please visit our Permissions help page.